protein
| target by MYC phosphorylating and blocking active repression by RB1 |
|
ZNF655 |
|
bound to cyclin D1 and has a phosphorylated T-loop, but is in an inactive conformation |
|
YY1 inhibited CDKN1A complex formation with CDK4 and CCND1 |
|
UCHL1 physically interacts with CDK1, CDK4, and CDK5, enhancing their kinase activity |
|
novel function of CCND1 in promoting cell cycle progression by enhancing STK38/STK38L kinase activity independent of CDK4 |
|
RUNX1T1 controls proliferation and the neurotoxic effect of microglia by epigenetically regulating CDK4 and LAT2 via its interaction with HDACs |
|
CIAPIN1 played an important role in the proliferation of liver cancer cells through increasing the expressions of cell cycle related proteins CCND1, CDK2, CDK4, and CCNE1 |
|
SHCBP1 promoted cell cycle progression by regulating the CDK4& |
|
8209;CCND1 cascade and suppressed CASP3, caspase PARP& |
|
8209;dependent apoptotic pathways |
|
RPS14 can act as a CDK4/6 inhibitor linking ribosome biogenesis defects to the main engine of cell cycle progression |
|
CDK4/CDK6 regulate lysosome biogenesis through TFEB/TFE3 |
Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
tumoral
|  
| amplification
|  
|  
|
in malignant glioblastoma, anaplastic astrocytoma, in diffuse large B cell lymphoma, osteosarcoma with OS9, SAS and PRIM1 and in sporadic breast carcinoma | constitutional
|  
|  
| --low
|  
|
in insulin deficient diabete | |